Ultragenyx Pharmaceutical: Q1 Earnings Insights

Ultragenyx Pharmaceutical RARE reported its Q1 earnings results on Thursday, May 4, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Ultragenyx Pharmaceutical missed estimated earnings by 17.68%, reporting an EPS of $-2.33 versus an estimate of $-1.98.

Revenue was up $20.56 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 10.03% increase in the share price the next day.

Here's a look at Ultragenyx Pharmaceutical's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -2.14 -1.81 -1.75 -1.76
EPS Actual -2.16 -2.43 -2.26 -2.19
Revenue Estimate 105.12M 96.20M 87.51M 83.65M
Revenue Actual 103.35M 90.70M 89.34M 79.94M

To track all earnings releases for Ultragenyx Pharmaceutical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!